Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2026 Jan 5;12:1671237. doi: 10.3389/fmed.2025.1671237

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2026 Duarte, Nóbrega, Vogt, Pereira, Vieira, Silva, Disessa, Mondini, Krug, Sant’Helena, Bundchen, Bohlke, Adamoli, Lima, Inda-Filho, Avesani, Reboredo, Ribeiro and the SARC-HD Study Group.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Bar charts illustrating the prevalence of sarcopenia across various subgroups: a) Gender, shows higher prevalence in males. b) Age, displays increased prevalence in those over sixty. c) Race, indicates higher rates in white individuals. d) Vascular access type, shows a higher prevalence with catheters. e) Dialysis method, reveals more cases with hemodiafiltration. f) Dialysis frequency, shows higher prevalence with conventional sessions. Percentage prevalence is represented on the y-axis, with statistical significance marked by p-values. — Prevalence of sarcopenia stages according to sex (A), age (B), ethnicity (C), vascular access (D), dialysis modality (E), and weekly dialysis frequency (F). AVF, arteriovenous fistula.